| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3B | $8.3B | $9.1B | $7.8B | $7.0B | $1.6B | $1.7B | $1.7B |
| Cost of Revenue | $4.3B | $5.1B | $5.3B | $4.7B | $4.1B | $3.7B | $3.8B | $3.8B |
| Gross Profit | $4.0B | $3.2B | $3.7B | $3.1B | $2.9B | $0.6B | $0.7B | $0.7B |
| R&D Expense | $0.7B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B |
| SG&A Expense | $1.9B | $2.0B | $2.0B | $1.8B | $1.7B | $1.5B | $1.5B | $1.6B |
| Operating Income | $1.7B | — | — | — | — | — | — | — |
| Net Income | $0.9B | $1.0B | $1.4B | $0.9B | $1.4B | $0.3B | $0.0B | $0.3B |
| EPS (Basic) | $7.69 | $8.32 | $12.03 | $8.02 | $11.69 | $2.26 | $0.07 | $2.84 |
| EPS (Diluted) | $7.67 | $8.28 | $11.95 | $7.97 | $11.58 | $2.25 | $0.07 | $2.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.2B | $11.2B | $11.3B | $10.8B | $10.7B | $7.3B | $6.1B | $6.3B |
| Current Assets | $3.9B | $3.9B | $4.9B | $3.6B | $3.1B | $2.7B | $3.0B | $2.8B |
| Cash & Equivalents | $0.5B | $0.5B | $1.1B | $0.5B | $0.7B | $0.7B | — | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.4B | $3.6B | $3.4B | $3.6B | $3.0B | $1.8B | $1.9B | $2.2B |
| Stockholders' Equity | $3.7B | $3.5B | $3.6B | $2.7B | $2.4B | $1.0B | $0.4B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $0.9B | $1.4B | $0.8B | $1.3B | $1.1B | $1.2B | — |
| Investing Cash Flow | $-0.2B | $-1.0B | $0.9B | $-0.0B | $-2.6B | $-0.6B | $0.2B | — |
| Capital Expenditures | — | — | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.3B | $-0.5B | $-1.7B | $-0.9B | $1.3B | $-0.8B | $-1.0B | — |